143 EFFICACY AND SAFETY OF INCREASING DOSES OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A IN TREATMENT NAIVE CHRONIC HCV PATIENTS

Authors :: Andrzej Horban
Waldemar Halota
Jenny Heathcote
Maciej Jabłkowski
Raf Crabbé
Saya V. Feinman
Robert Flisiak
J. S. Liz
Wiesław Kryczka
Pietro Scalfaro
Carmen Vandelli
Hervé Porchet
Giuseppe Mazzella
Source :: Journal of Hepatology. 48:S62
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Therapy naive
Hepatology
business.industry
Pegylated interferon alpha 2a
Medicine
Pharmacology
business
Cyclophilin

Full Text Access

Tools